News
Key to more effective vaccines revealed
Researchers from the Centenary Institute and the University of Sydney have made a major discovery in vaccine science, gaining new insights into delta inulin as a crucial vaccine component. Their findings offer a promising pathway for advancing the next generation of vaccines.

-
Striking science images reveal the beauty of medical research
A breathtaking collection of images capturing the wonder and complexity of medical science has been unveiled through the Centenary Institute’s 2025 When Art Meets Science image prize competition.News Type: Media releaseDate -
Centenary Institute delivers Tour de Cure milestone
A recent discovery from the Centenary Institute has been recognised as the 200th scientific breakthrough funded by cancer charity Tour de Cure since it began supporting research in 2007.News Type: Research NewsDate -
ABC radio interviews Professor Geoff McCaughan
Professor Geoff McCaughan, senior researcher at the Centenary Institute’s Centre for Cancer Innovations, has shared his expert insights on ABC radio, discussing the growing global burden of liver cancer.News Type: Media coverageDate -
Centenary Institute and Cure the Future join forces to tackle rare diseases
The Centenary Institute and Cure The Future Foundation have announced a new philanthropic partnership to accelerate research into life-changing treatments for rare genetic diseases and cancers.News Type: Media releaseDate -
New COVID-19 vaccine candidate shows strong protection against multiple variants
A promising new COVID-19 vaccine candidate developed by researchers at the Centenary Institute and the University of Sydney has shown strong potential to protect against both current and emerging coronavirus variants. By targeting features shared by a range of coronaviruses, the vaccine is designed to offer broader and longer-lasting protection as the virus continues to evolve.News Type: Media releaseDate -
New route into cells could make gene therapies safer
Scientists from the Centenary Institute and the University of Sydney have made a landmark discovery that could lead to safer and more effective gene therapies for a range of serious genetic disorders including Duchenne muscular dystrophy, Pompe disease and haemophilia.News Type: Media releaseDate -
Centenary researchers awarded TIA Pipeline Accelerator Grants
Two researchers from the Centenary Institute have secured competitive Pipeline Accelerator Grants from Therapeutic Innovation Australia (TIA), supporting the development of promising medical innovations.News Type: Research NewsDate -
Research grant to tackle Alzheimer’s disease
A research team led by Professor Jennifer Gamble from the Centenary Institute’s Centre for Healthy Ageing has been awarded a prestigious Catalyst Partnership Grant from the Heart Foundation.News Type: Research NewsDate -
Prestigious editorial award for Professor Gorrell
Professor Mark Gorrell from the Centenary Institute’s Centre for Cancer Innovations has been awarded a Springer Nature Editorial Contribution Award celebrating his outstanding editorial work for the highly respected journal Scientific Reports. The award recognises editorial board members who have made a notable contribution to the journal’s peer-review and publishing processes. Professor Gorrell has served ...News Type: Research NewsDate -
Serena Li, inaugural Chair of Centenary’s ReST Association
Serena Li, a research assistant at the Centenary Institute, has recently been appointed as the Chair of the newly established ReST (Research Assistants, Support and Technicians) Association.News Type: ProfilesDate -
Centenary Institute hosts TB research symposium
The Centenary Institute has hosted the 2025 Annual Research Symposium of the ‘Centre of Research Excellence in Tuberculosis Elimination (TB-CRE)’.News Type: EventsDate -
New discovery could improve treatment for people with haemophilia A
Researchers from the Centenary Institute have uncovered a reason why some people with haemophilia A develop resistance to their critical treatment, paving the way for the development of more effective therapies.News Type: Media releaseDate